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In patients undergoing cardiac resynchronization therapy with defibrillator (CRT-D) implantation for left ventricular
systolic dysfunction (LVSD) accompanied by permanent atrial fibrillation (AF), generally, the unused atrial port is
plugged at device implantation. We describe an alternative use for the atrial-port in this case report.
A 43 year old gentleman with LVSD due to left ventricular non-compaction (LVNC) and AF of unknown dura-
tion underwent a CRT-D implantation after optimization of cardiac failure treatment. The atrial-port which would
otherwise have been plugged was connected to a high right ventricular septal (RVS) pacing-lead and the shock-lead
was positioned at the right ventricular apex (RVA). This approach permitted modified cardiac resynchronization in a
high RVS to left ventricular (LV) and RVA pacing sequence using the high RVS and LV pacing combined with a
shock vector including the RV apex. A standard CRT-D device with a minimum programmable A–V delay of
30 ms (technically RVS to LV delay in the ‘DDD’ pacing mode) was used. The device was programmed to a
‘DDD’ pacing mode (sequential multi-site ventricular pacing with some programmability). The mode switch oper-
ation was programmed ‘OFF’ since atrial sensing is unavailable. Device-delivered shocks did not cardiovert the
patient back to sinus rhythm suggesting that the AF was permanent (no prior cardioversion attempts were made
on the presumption that the chances of maintaining sinus rhythm, given the underlying cardiac condition, were
low). Subsequently, the patient required radio-frequency ablation of the atrio-ventricular node for conducted AF.
Symptomatic, echocardiographic and radiological improvement preceded atrio-ventricular node ablation.
Conclusion: Amongst AF patients with permanent AF undergoing CRT-D implantation, those patients who are
likely to have the CRT-D device atrial-ports plugged could benefit from having both the options of (i) a RVA shock
vector as well as (ii) a high RVS-pacing feasible, by utilizing the atrial-port of a conventional CRTD device for a RVS
pacing lead, should a RVA shock-lead position be preferred. New device programming algorithms will be necessary
to make patient-customized programming in this lead configuration flexible, more useful clinically and easy.
 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
C
A
SE R
EPO
RT
214 CHASE ET AL
DUAL-SITE RIGHT VENTRICULAR AND LEFT VENTRICULAR PACING IN A PATIENT
J Saudi Heart Assoc
2013;25:213–218Keywords: Cardiac resynchronization therapy with defibrillator (CRT-D), Left ventricular systolic dysfunction
(LVSD), Atrial fibrillation (AF), Left ventricular non-compaction (LVNC), High right ventricular septum (high RVS),
Right ventricular apex (RVA), Left ventricle (LV), Atrio-ventricular node (A-VN), Radio-frequency ablation (RFA)Introduction
The benefits of medical therapy followed bycardiac resynchronization therapy (CRT) in
patients who qualify for such treatment are well
known [1,2]. In patients with left ventricular sys-
tolic dysfunction and permanent atrial fibrillation,
CRT-D implant procedure usually involves plug-
ging the atrial-port, unless it is preferred to retain
the atrial sensing option. The implanting physi-
cian’s personal preference or compelling patient’s
anatomy or another such factor would determine
whether the RV shock-lead is positioned at the
RVA or in the high RVS. The debate as to which
RV pacing site is superior is far from over. Further,
many operators still prefer the RVA site for de-
vice-delivered shocks and at times others whose
routine practice regarding positioning the RV
shock-lead involves the RVS also end up having
to change to a RVA site if a high defibrillation
threshold is encountered. In any case, RV shock-
lead location limits options in the sense that the
same site is going to be used for pacing and for de-
vice-delivered shocks. Cardiac resynchronization
therapy requires predominant multi-site ventricu-
lar pacing (minimal, if not no ventricular sensing,
at times with the aid of atrio-ventricular node
ablation) for maximal benefits. Flexibility in device
programming for allowing multiple options in var-
ious combinations of the LV, RVS and RVA is
presently unavailable.
In this case report, we describe a modification of
the conventional CRT-D implant procedure with a
view to utilize the atrial port for RVS pacing with a
standard bipolar active fixation pacing lead and
utilizing the shock lead in the RVA for device-
delivered shock which includes the apical region
of the heart. This might become important in a pa-
tient with significant cardiomegaly and a high
defibrillation threshold from the RVS. Unfortu-
nately, when used in this manner, the lowest pro-
grammable A⁄–V delay (⁄ the atrial port is actually
connected to the RVS, making it a RVS-V delay)
which is 30 ms in some devices, mandates that
RVS pacing occurs first, followed by left ventricu-
lar (LV) or RVA depending on how the other ven-
tricular leads and V–V delay (‘non RVS’ V-leads)
are programmed. In addition, mode-switch opera-
tion would need to be turned ‘OFF’ as there is no
atrial sensing and for the same reason, 1:1 V–A
relationship algorithms would become meaning-
less in device therapy programming. We pre-sumed that a 30 ms early septal pacing would
not have a significant impact (markedly prolonged
baseline QRS duration) and in the event of not
seeing a significant response in terms of clinical
improvement, we were prepared to fall back on
to a standard bi-ventricular ‘VVIR’ mode.Clinical findings and investigation reports
A 43 year old gentleman presented with pro-
gressive dyspnoea on exertion (New York Heart
Association symptom class III at admission) for
five years, pedal oedema/paroxysmal nocturnal
dyspnoea for one month in spite of medical treat-
ment given at his primary hospital and was re-
ferred for refractory symptoms. There was no
significant history suggesting alcohol or substance
use. The jugular venous pressure was elevated
and pedal oedema was present. The pulse was
irregularly irregular with a rate of 74 beats per
minute and the blood pressure was 110/80 mm
Hg. A pansystolic murmur could be heard at the
apex. There was no other significant clinical find-
ing at examination.
Routine 12 lead ECG confirmed the presence of
atrial fibrillation and left bundle branch block with
a QRS duration of 174 ms (see Fig. 1). The chest X-
ray revealed cardiomegaly (cardio-thoracic ratio of
0.75) and evidence of pulmonary venous conges-
tion. Mild pre-renal form of uraemia was present
but otherwise clinical pathology and biochemistry
testing did not reveal any other abnormality.
Thyroid function and liver function was normal.
Echocardiography revealed left ventricular non-
compaction (confirmed later by magnetic reso-
nance imaging), dilated left ventricle (LVIDD/
IDS – 67/58 mm) with global hypokinesia, severe
left ventricular systolic dysfunction (LV ejection
fraction by Simpsons method – 22%), moderate
mitral and tricuspid regurgitation and evidence
of pulmonary hypertension. The pulmonary arte-
rial pressure at cardiac catheterization was 59/
31 mmHg with a mean of 40 mmHg and the left
ventricular end-diastolic pressure was elevated
at 25 mmHg. Coronary angiography did not reveal
any significant flow limiting disease.Treatment details
The patient’s therapy with Carvedilol/Ramipril/
Diuretics/Spirono lactone/Digoxin/oral anticoagu-
Figure 1. 12 lead ECG tracings; A – Baseline; B – Post CRT-D (QRS d- QRS duration).
Figure 2. LAO view during AV node ablation procedure by
retrograde aortic approach; high RVS, RVA and LV lead orientation.
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based on clinical response. The patient was dis-
charged home and was advised cardiac resynchro-
nization therapy with defibrillator implantation.
The AF was considered to be permanent given
that no details regarding the onset were available
and the cardiac diagnosis was left ventricular non-
compaction. As such, no other treatable causes for
AF, other than the heart-failure, such as thyrotox-
icosis were identified. A rate control line of man-
agement for atrial fibrillation was considered
most appropriate at this stage. The justification
for this decision was evident subsequently, when
the patient had device-delivered shocks which
defibrillated his heart back to an AF rhythm from
VF during device implantation. Additionally, re-
view of subsequent inappropriate (due to con-
ducted AF) shock-episode tracings did not
demonstrate reversion to a regular rhythm either.
The chances of this patient remaining in sinus
rhythm after cardioversion, even if that were pos-
sible, were considered low. CRT-D implantation
was performed on 18/03/2010, about five weeks
after initial evaluation at our centre.
Informed consent was obtained from the patient
according to standard hospital procedure and the
possibility of using the atrial-port for a RV septal
pacing lead which is not currently standard prac-
tice was fully explained. It was also explained to
the patient that in the event of a suspicion of del-
eterious effects, switching to a VVIR mode would
by-pass in entirety the pacing from the RVS in
which case standard ‘bi-ventricular’ VVIR option
would be operative. The CRT-D procedure was
performed after withholding oral anticoagulant
therapy under cover of twice daily sub-cutaneous
Enoxaparine, using conscious sedation/prophy-
lactic antibiotics/local anaesthetic infiltration. Aleft sub-clavicular approach was used for a cepha-
lic vein cut-down and this permitted manipulating
a Medtronic Sprint Quattro 65 cm active fixation
RV shock lead to the right ventricular apex. Sub-
clavian vein punctures were used for the second
right ventricular lead-a 58 cm active fixation Med-
tronic 4076 lead positioned to pace high in the ba-
sal right ventricular septum and for the left
ventricular lead-a 88 cm 4196 Medtronic bipolar
lead positioned in a posterolateral tributary of
the coronary sinus close to the left ventricular ba-
sal region (see Fig. 2). The pacing parameters were
acceptable and a Medtronic Maximo II CRT-D de-
vice was connected to the leads at the appropriate
ports with the exception of the RV septal pacing
lead which was connected to the atrial port.
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cessful 15 J shock delivered through the device
defibrillating the heart back to previous atrial
fibrillation rhythm with a shock impedance of
52 Ohms and good sensing at a sensitivity setting
of 1.5 mV. The device was programmed to a mod-
ified multi-site CRT (i.e., DDDR, which essentially
is multi-site ‘ventricular pacing only’ mode in this
context, lower rate 70 beats per minute, upper
sensor and tracking rate 130 beats per minute)
30/20 ms RV septum to LV to RV apex delays
(since the RV septal lead was connected to the at-
rial port, this is shown as AV delay by the device)
and mode switch was turned ‘OFF’ for the same
reason. Both sensed and paced ‘A’–V delays were
programmed at 30 ms. After the initial RVS/LV/
RVA pacing amplitude @3.5/4/4 V, respectively
(0.4 ms pulse width) immediately post-implant, it
was subsequently programmed to 1/4/3 V, respec-
tively (0.4 ms pulse width) based on capture
threshold measurements. Although no diaphrag-
matic capture was evident at implant procedure,
later on, an increase in LV capture threshold was
noted with diaphragmatic stimulation and hence
the LV lead pacing configuration was changed
from LV tip to ring and LV tip to RV (A) coil was
programmed. Three zones for therapies were pro-
grammed (fast VT zone via VF) ‘ON’ with ATP
during charge for VF/before shocks for cardiover-
sion in the VT and FVT zones and all lead imped-
ance measurements were found to be in the
acceptable range. PR Logic based algorithms were
programmed ‘OFF’. ‘Onset’ as enhancement was
left ‘ON’.
The patient had to be brought back to the hospi-
tal for multiple inappropriate shocks delivered
through device for conducted rapid AF (highly
variable R–R interval seen in both the RVS and
RVA channels with no suggestion of T-wave
over-sensing) probably precipitated by increasedTable 1. Distribution of ECG and ultrasound pulsed tissue Doppler
velocity onset delays by pacing modes.
Intervals (ms) meas
RVS + 30 ms LV + 20
RVA (BiV DDD* mo
Surface ECG QRS duration 173
QRS onset to LV basal septum Sm onset 151
QRS onset to basal lateral LV Sm onset 155
QRS onset to basal anterior LV Sm onset 141
QRS onset to basal inferior LV Sm onset 151
QRS onset to basal lateral RV Sm onset 141
Sm onset – Pulsed Wave Tissue Doppler Myocardial Systolic Velocity onset; LV
BiV – Biventricular pacing.
* Selection of DDD mode in this situation implies multi-site ventricular pacphysical activity level as a result of decreased
symptoms. The patient was re-admitted for Atri-
o-ventricular node ablation to minimize con-
ducted AF. This was successfully performed by
retrograde Aortic approach as it was unsuccessful
using the venous approach from the right-side of
the ventricular septum following which the ven-
tricular pacing increased from 80% to 100%. The
12-lead surface ECG showed a QRS duration of
126 ms with positive deflections in the inferior
leads and a negative deflection in the avL lead
and a good transition on the anterior chest leads
suggesting good CRT pacing result (see Fig. 1). A
subsequent ECG and Pulsed Wave Tissue Dopp-
ler guided assessment of degree of inter and in-
tra-ventricular delays in different pacing modes
demonstrated a clearly shorter surface ECG QRS
duration in the LV + 30 ms RVA and RVS + 30 ms
LV + 20 ms RVA pacing modes compared with
RVS or RVA alone (see Table 1) [3]. Similarly, once
again, a clearly shorter surface ECG QRS onset to
Pulsed Wave Tissue Doppler myocardial systolic
velocity onset intervals suggesting better intra
and inter-ventricular delays based on the Pulsed
Wave Tissue Doppler derived pre-ejection period
were noted in these modes and the LV + RVA
mode was slightly better of the two. Maximum in-
ter-ventricular delay occurred in the RVS only
mode and in the RVA only mode, all the intervals
measured were very prolonged but with much
less intra and inter-ventricular dyssynchrony.
Since the improvement in the patient occurred
in the RVS to +30 ms LV to +20 ms RVA mode,
the basic parameters were not altered after the
Pulsed Wave Tissue Doppler assessment of opti-
mal cardiac resynchronization parameters except
for increasing the LV to RVA delay to 30 ms. Con-
ducted AF response and V-rate stabilization was
turned ‘OFF’ after atrio-ventricular node ablation.
V-sense response and PVC response was leftbased QRSD and segmental pulsed tissue Doppler myocardial
ured based on pacing site(s)
ms
de)
RVS alone
(AAI mode)
RVA alone
(VVI mode)
LV + 30 ms RVA
(BiV VVI mode)
197 254 169
197 208 144
165 190 148
141 204 158
183 232 158
130 197 155
– Left Ventricle; RV – Right Ventricle; RVS – RV septum; RVA – RV apex;
ing in RVS? LV? RVA sequence.
Figure 3. A & B – Baseline chest X ray and MR image; C & D – Serial follow up chest X ray images.
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improvement in effort tolerance and was asymp-
tomatic at last check one and a half years post
implantation. Serial chest radiographs showed
progressive decrease in the cardiac size (see
Fig. 3) and echocardiography showed significant
improvement in the overall left ventricular func-
tion to almost near normal with a LVIDD/IDS of
44/32 mm, however, with persisting features of left
ventricular non-compaction.Discussion
This case report demonstrates the benefits of
optimal medical management combined with pro-
ven technology. In addition, a novel use for the at-
rial-port in this patient with atrial fibrillation
where it would otherwise have been left plugged.
The patient showed a good CRT result as evi-
denced by a narrower QRS on surface ECG and
the clinical response notwithstanding the verylimited options available in the various ventricular
pacing permutations possible because of the pro-
gramming features of the atrial channel which in
this situation is used as a ventricular channel.
There is no way of proving in this case that the
benefit seen in the form of clinical response to
treatment accrues from anything beyond cardiac
resynchronization therapy in a general sense and
it definitely is not possible to attribute any benefit
to the RVS-first pacing mode. In this case report
the patient may well have improved significantly
due to just optimal medical management, ade-
quate ventricular rate control for AF and conven-
tional CRT-D because all of these modalities
have incremental value in the management of
such patients. Whether or not using the atrial port
in this fashion is beneficial remains to be evalu-
ated by further studies. If the device industry
takes up the challenge of better programmability
of ‘A’–V delays and V–V delays to accommodate
this form of multi-site pacing, more room for finer
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cedure (such as simultaneous or LV to RV septum
with or without ventricular apex pacing).Conclusion
This case report showcases the possibility of
non-conventional sequential multi-site pacing
(RV septum to LV to RV apex) being feasible using
the standard CRT-D device in patients with atrial
fibrillation where the atrial port would otherwise
be left plugged.References
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